KYVIVY Trademark
Serial Number: 98199140
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP
1055 THOMAS JEFFERSON ST. NW, SUITE 400
WASHINGTON, DC 20007
United States
Trademark Details
Filing Date
September 27, 2023
Registration Date
Not Registered
Published for Opposition
April 2, 2024
Goods & Services
Pharmaceutical preparations for the treatment of blood conditions; Pharmaceutical preparations for the treatment of transplant diseases, illnesses, and conditions; Pharmaceutical preparations for renal transplant diseases, illnesses, and conditions; Pharmaceutical preparations for kidney diseases, illnesses and conditions; Pharmaceutical preparations for treatment of antibody mediated rejection in adult renal transplant recipients; pharmaceutical preparations to treat hematology diseases, illnesses and conditions; Pharmaceutical preparations for the treatment of emphysema diseases, illnesses and conditions; Pharmaceutical preparations for the treatment of respiratory diseases, illnesses and conditions; Pharmaceutical preparations for the treatment of respiratory diseases, illnesses and conditions, namely, acute respiratory distress syndrome, ARDS; Pharmaceutical preparations for the treatment of respiratory diseases, illnesses and conditions, namely, antibody for the treatment of acute respiratory distress syndrome, ARDS; Pharmaceutical preparations for the treatment of respiratory diseases, illnesses and conditions, namely, for the treatment of Hereditary Angioedema, HAE; Pharmaceutical preparations for the treatment of respiratory diseases, illnesses and conditions, namely, antibody for the treatment of Hereditary Angioedema, HAE; Pharmaceutical preparations for the treatment of lung diseases, illnesses and conditions; Pharmaceutical preparations for the treatment of lung diseases, illnesses and conditions, namely, Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; Pharmaceutical preparations for the treatment of lung diseases, illnesses and conditions, namely, antibody for the treatment of Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD